The full form of TLR is Toll-like receptors.
TLRs are a family of proteins found on the surface of immune cells. They recognise specific molecules from invading pathogens and activate the immune system to fight infection. They are the first line of defence against invading pathogens and play a crucial role in initiating and maintaining the body’s immune response.
TLRs are responsible for recognising a variety of pathogens, including bacteria, fungi, and viruses, as well as ligands of host origin, such as damage-associated molecular patterns and endogenous modulators. After the recognition of molecules, TLRs trigger an immune response by signalling the production of cytokines, proteins that regulate the activity of other immune cells, and chemokines, which attract immune cells to the site of infection.
TLRs regulate the body’s inflammatory response and initiate tissue repair, and plays roles in cell death and survival. In addition, TLRs can modulate T-helper and natural killer cells' activity and recognise allergens. Through their interactions with other molecules and cells, TLRs are involved in various immune functions. They also play an essential role in maintaining health and protecting against infection.
How TLRs Recognise Pathogens: TLR Ligands and Signaling Pathways
Toll-like receptors (TLRs) are a family of receptors that recognise pathogen-associated molecular patterns (PAMPs) and play an essential role in innate immune responses. TLRs are expressed on the cell surface and in endosomes and identify a variety of PAMPs, including lipopolysaccharide (LPS), lipoteichoic acid (LTA), peptidoglycan (PGN), flagellin, and double-stranded RNA (dsRNA).
Upon activation, TLRs recruit various intracellular proteins, activate signalling pathways and induce the expression of pro-inflammatory cytokines and type I interferons.
TLRs generally recognise bacteria, fungi, and viruses through various ligands derived from their cell wall. TLRs can identify different carbohydrates, lipids, and proteins, each TLR recognising a unique set of ligands.
For example, TLR2 can recognise various components of bacterial cell walls, including lipoproteins, lipopolysaccharides, and lipoteichoic acids. TLR4 recognises LPS from Gram-negative bacteria. TLR5 recognises flagellin from Gram-negative bacteria. TLR7 and TLR8 recognise viral nucleic acids.
Once the TLR recognises a pathogen-associated ligand, it activates an intracellular signalling pathway. This pathway consists of several steps, including the recruitment of adaptor proteins, the activation of kinases, and the activation of transcription factors.
These pathways activate NF-κB and AP-1, which control the expression of pro-inflammatory cytokines, chemokines, and type I interferons. The activation of these pathways initiates the innate immune response and helps to fight the infection.
TLR Signaling in Antiviral and Antibacterial Responses
TLR signalling is a mechanism by which the body can recognise and respond to pathogens and other dangers. In the case of antiviral and antibacterial responses, TLR signalling is crucial in helping the body initiate an appropriate immune response to the threat. TLR signalling works by detecting molecules known as Pathogen-Associated Molecular Patterns (PAMPs).
TLR receptors on the surface of immune cells recognise these PAMPs and activate a signalling cascade that ultimately leads to the activation of immune pathways, such as the induction of interferons and the production of cytokines. These immune pathways are responsible for mounting an appropriate defence against the threat and ultimately eliminating the pathogen.
Additionally, TLR signalling can also lead to antigen presentation and the activation of T cells. This plays a critical role in mediating the adaptive immune response. Thus, TLR signalling plays a crucial role in innate and adaptive immune responses to viruses and bacteria, allowing the body to defend against these invading pathogens effectively.
TLR-Mediated Inflammation and Immune Regulation
TLR-mediated inflammation is the activation of the immune system in response to the presence of foreign molecules, such as viruses and bacteria, and their products. The recognition of these molecules triggers the activation by the Toll-like receptors (TLR) on the surface of the cells.
The activated TLR then produces pro-inflammatory and/or anti-inflammatory molecules such as cytokines, chemokines and other signalling molecules. TLR-mediated inflammation can significantly affect the immune system, resulting in both beneficial and detrimental effects.
The activation of the immune system through TLR-mediated inflammation leads to an increase in the number of cells available to fight off infection, such as macrophages and dendritic cells, as well as an increase in the production of cytokines and other molecules involved in the immune response.
On the other hand, too much TLR-mediated inflammation can result in an exaggerated or inappropriate immune response. This will lead to chronic inflammation and even autoimmunity.
TLR-mediated inflammation can be regulated through various mechanisms, including cytokines, chemokines and other signalling molecules. Additionally, small molecules and natural compounds modulate TLR-mediated inflammation and regulate the immune response.
These molecules and compounds can target specific components of the immune response such as cytokine production. This reduces inflammation and restore balance to the immune system.
TLR Signaling in Disease Pathogenesis
TLR signalling plays a crucial role in the pathogenesis of many diseases. TLR receptors recognise danger signals and initiate an inflammatory response, allowing cells to defend themselves against foreign agents or cancerous cells. This is an integral part of the body’s defence and response system, as it helps differentiate between harmful and beneficial signals.
Dysregulation of TLRs leads to an overactive immune system and the release of pro-inflammatory cytokines that can lead to autoimmune and inflammatory diseases, including rheumatoid arthritis, inflammatory bowel disease, septic shock, and asthma. Similarly, if the TLR receptors are not activating the body’s immune system, characteristics associated with metastatic cancer and other chronic diseases can develop.
TLR signalling is essential for the maintenance of proper health and functioning. It ensures the body’s immune system response is adequate to defend against foreign organisms and diseases.
Although, there is still much to be learned, research into TLR signalling insighted into ways to improve health and treat disease. For example, drugs and probiotics target various TLR receptors and modulate their activity to find balance and control the body’s response.
Future Directions in TLR Research and Therapeutic Targeting
The study of Toll-like Receptors (TLRs) has been at the front end of biomedical research for many years. Also, TLRs are essential for detecting potential threats and keeping our immune systems functioning correctly. And, Their role in the development and progression of numerous diseases, from infection to cancer, means that there are plenty of opportunities for research and therapeutic targeting of TLRs.
In the future, scientists hope to understand better the different forms of TLR expression in other patients and how this affects the immune system. This could allow for personalised diagnostic testing that would enable targeted and effective treatments.
In addition, TLR research could offer new treatments to combat infectious diseases. It is already demonstrated that a small group of engineered molecules could boost immune response in mice models of various viruses, such as SARS-CoV-2. Further research in this area has the potential to give us new treatments for these and other infectious diseases.
Finally, another potential direction for TLR research is developing novel therapies to tackle cancer. TLR agonists, such as flagellin, could stimulate the immune system, activate an anti-cancer response, and target cancer cells directly.
[wp-faq-schema title=" Full Form of TLR FAQs" accordion=1]
